• Nutanix, Inc., a hybrid multicloud software provider, recently presented at the HIMSS 2026 Global Health Conference & Exhibition in Las Vegas and is preparing to host its 2026 Investor Day on April 7 in Chicago, where leadership will outline company strategy and provide a financial update.
• At the same time, institutional positioning has been shifting, with Schroder Investment Management Group cutting its Nutanix stake by 43.4% while other funds adjust holdings, against a backdrop of debate over valuation, including at least one DCF analysis suggesting the shares may be trading below estimated intrinsic value.
• Next, we will examine how anticipation around Nutanix’s upcoming Investor Day could influence the existing investment narrative for the company.

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Nutanix Investment Narrative Recap

To own Nutanix, you have to believe in the long term need for hybrid multicloud infrastructure and the company’s ability to turn that demand into profitable, recurring software revenue. In the near term, the key catalyst is the April Investor Day, where management will refresh its strategy and financial framework; recent shifts in institutional positioning and valuation debate highlight sentiment risk, but they do not materially change the core business risk around competition and pricing in hyper-converged infrastructure.

The upcoming Investor Day announcement is most relevant here, because it sits at the intersection of these questions about value and execution. With Nutanix already guiding FY2026 revenue to US$2.80 billion to US$2.84 billion, investors will be watching closely for updated views on growth, margins, and capital allocation that could either reinforce or challenge the recent DCF-based view that the shares trade below estimated intrinsic value.

Yet, while the headlines focus on potential upside, investors should be equally aware of how intensifying competition and pricing pressure could...

Nutanix's narrative projects $3.9 billion revenue and $513.0 million earnings by 2028.

Uncover how Nutanix's forecasts yield a $58.87 fair value, a 50% upside to its current price.

Exploring Other Perspectives

Compared with consensus, the most pessimistic analysts were assuming Nutanix revenue would grow just 9.7% annually and earnings reach about US$622.8 million by 2028, so if you worry that OEM driven delays or slower VMware migrations could weigh on results more than the market expects, this lower bar might feel more realistic and is a useful reminder that reasonable people can look at the same AMD partnership and shifting institutional positions and still reach very different conclusions about risk and reward.

Explore 5 other fair value estimates on Nutanix - why the stock might be worth just $56.29!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Nutanix research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Nutanix research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Nutanix's overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
• The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.